German Chancellor Merz discusses BioNTech and capital markets
Chancellor Friedrich Merz noted that BioNTech achieved massive success through German research support, but chose to list on Nasdaq in New York rather than
Chancellor Friedrich Merz noted that BioNTech achieved massive success through German research support, but chose to list on Nasdaq in New York rather than